Faruqi & Faruqi, LLP investigates claims on behalf of Pasira investors By Investing.com

Spread the love

Farooqui & Farooqui, LLP Securities Litigation Partners James (Josh) Wilson Pasira encourages investors who have lost more than $75,000 to contact him directly to discuss their options.

If you have a loss of more than $75,000 Pasira Between August 2, 2023 and August 8, 2024 And you want to discuss your legal rights, call Farooqui & Farooqui Partner Josh Wilson live as if 877-247-4292 Or 212-983-9330 (Ex. 1310).

(You can click here for more information)

NEW YORK, NY–( News File – Jan 19, 2025 ) – Faruqi & Faruqi, LLP, a leading national securities law firm, has acquired Pasira Biosciences Inc. (NASDAQ: PCRX ) and reminds investors March 14, 2025 deadline To seek the role of lead plaintiff in a federal securities class action against the company.

Farooki & Farooki is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The organization Since its inception in 1995, it has returned hundreds of millions of dollars to investors. Check out www.faruqilaw.com.

According to the complaint, On August 9, 2024, Pacira announced that a New Jersey district court had dismissed the ‘495 patent, finding that eVenus had not infringed the ‘495 patent for obviousness and pending infringement. The petition said the ruling came shortly after Pasira submitted additional evidence to the court, which the court said would have no effect on its decision. The complaint further alleges that this ruling, second to the same court’s ruling, affected the claim construction of Pacira’s ‘495 and ‘336 patents for eVenus patronage.

According to the complaint, Pasira’s claim that the ‘495 patent was rejected surprised investors and analysts who immediately reacted to the disclosure. The complaint alleges that the value of Pasira’s common stock has declined substantially. According to the complaint, from a closing market price of $22.36 per share on August 8, 2024, Pasira’s stock price fell to $11.70 per share on August 9, 2024, a drop of more than 47% in one day, resulting in damages. Investors.

The court-appointed lead plaintiff is the investor with the greatest financial interest in obtaining the relief sought by the class, who is sufficient and the class members who lead and control the litigation on behalf of the class members. Any member of the mandatory class may ask the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain as a residual class member. Your ability to participate in any recovery is not affected by the decision to serve as lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Pasira’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Notice of attorney. The law firm responsible for this announcement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Past results do not guarantee or predict similar results for any future case. We welcome the opportunity to discuss your case. All communications will be treated confidentially.

To view the source of this press release, please visit https://www.newsfilecorp.com/release/237458.